GHIG is currently working with the London School of Hygiene and Tropical Medicine (LSHTM) as part of the European Union (EU) funded ZikaPLAN project. The ZikaPLAN initiative is composed of…
In response to the growing concerns with antimicrobial resistance (AMR), particularly for the developing world, GHIG continues to collaborate with the London School of Hygiene and Tropical Medicine (LSHTM) and…
GHIG participated in the 2nd annual POC Day in Bogota to support the uptake of POC testing in Latin America. GHIG provided a one-day training workshop on implementation of POC.…
GHIG was asked to serve as an advisor collaborating with Cambridge Economic Policy Associates (CEPA) to evaluate the return on investment of early infant diagnosis (EID) and viral load (VL)…
Equip Health is the first African-led global consortium to deliver rapid scale-up of innovative HIV treatment and prevention solutions across 17 PEPFAR countries. In 2017, GHIG accompanied the National Health…
Ultrasensitive antigen tests are needed for early detection of numerous infectious diseases, and for surveillance and monitoring progress towards disease elimination. GHIG and IDC/LSHTM worked with the Global Good Fund…
Recent advances with Prevent of Mother-to-Child Transmission (PMTCT) and Early Infant Diagnosis (EID) programs due to Option B+ and at birth testing have created challenges with specificity of EID testing…
The World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) is a global programme of scientific collaboration that helps facilitate, support and influence efforts to…
GHIG supported the London School of Hygiene and Tropical Medicine (LSHTM) with a series of systematic reviews of hepatitis diagnostics for the 2016 World Health Organization (WHO) Hepatitis Guidelines.
In 2015, GHIG provided technical input to support the World Health Organization (WHO) HIV/AIDS Treatment and Care Unit normative documents for the ARV Guidelines. These documents informed the 2015 update…